Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I multiple-dose study of S-001000 in Japanese healthy adult males
jRCT2071210091Phase 1Completed
- Sponsor
- Sato Pharmaceutical
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in gout and hyperuricemia comparing S-001000 BID with Placebo BID (2 arms). Primary endpoints: Safety endpoints and Pharmacokinetic endpoints. Started Oct 2021; status: completed.
02
Drugs
S-001000
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on jRCT2071210091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210091.